Oxandrolone Patent Expiration
Oxandrolone is Used for promoting weight gain after weight loss in specific patient populations. It was first introduced by Savient Pharmaceuticals Inc
Oxandrolone Patents
Given below is the list of patents protecting Oxandrolone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Oxandrin | US5872147 | Use of oxandrolone in the treatment of chronic obstructive pulmonary disease |
Dec 05, 2017
(Expired) | Savient Pharms |
| Oxandrin | US6576659 | Use of oxandrolone in the treatment of burns an other wounds |
Dec 05, 2017
(Expired) | Savient Pharms |
| Oxandrin | US6828313 | Use of oxandrolone in the treatment of burns and other wounds |
Dec 05, 2017
(Expired) | Savient Pharms |
| Oxandrin | US6090799 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
Jul 18, 2017
(Expired) | Savient Pharms |
| Oxandrin | US6670351 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
Oct 20, 2012
(Expired) | Savient Pharms |
Oxandrolone's Family Patents
Explore Our Curated Drug Screens
Oxandrolone Generic API Manufacturers
Several generic applications have been filed for Oxandrolone. The first generic version for Oxandrolone was by Upsher Smith Laboratories Llc and was approved on Dec 1, 2006. And the latest generic version is by Roxane Laboratories Inc and was approved on Jul 10, 2007.
Given below is the list of companies who have filed for Oxandrolone generic, along with the locations of their manufacturing plants worldwide.
1. PAR PHARM
Par Pharmaceutical Inc has filed for 2 different strengths of generic version for Oxandrolone. Given below are the details of the strengths of this generic introduced by Par Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Jun 22, 2007 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 22, 2007 |
Manufacturing Plant Locations New
Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
2. ROXANE
Roxane Laboratories Inc has filed for 2 different strengths of generic version for Oxandrolone. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jul 10, 2007 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Jul 10, 2007 |
3. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Oxandrolone. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 1, 2006 |
| 10MG | tablet | Discontinued | ORAL | N/A | Dec 1, 2006 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
4. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 2 different strengths of generic version for Oxandrolone. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 1, 2006 |
| 10MG | tablet | Discontinued | ORAL | N/A | Mar 22, 2007 |